Caroline Mary

1.8k total citations
34 papers, 1.1k citations indexed

About

Caroline Mary is a scholar working on Immunology, Oncology and Transplantation. According to data from OpenAlex, Caroline Mary has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 7 papers in Oncology and 5 papers in Transplantation. Recurrent topics in Caroline Mary's work include T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (15 papers) and Immunotherapy and Immune Responses (13 papers). Caroline Mary is often cited by papers focused on T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (15 papers) and Immunotherapy and Immune Responses (13 papers). Caroline Mary collaborates with scholars based in France, United States and Mali. Caroline Mary's co-authors include Nicolas Poirier, Bernard Vanhove, Gilles Blancho, Nahzli Dilek, Paméla Gasse, Bruno Schnyder, Shizuo Akira, Isabelle Couillin, Silvia Schnyder‐Candrian and Isabelle Guénon and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Caroline Mary

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Mary France 16 611 206 199 165 141 34 1.1k
Rebecca A. Shilling United States 17 362 0.6× 164 0.8× 145 0.7× 98 0.6× 268 1.9× 33 799
William van der Touw United States 12 985 1.6× 49 0.2× 243 1.2× 127 0.8× 104 0.7× 25 1.3k
Tracy Goodpaster United States 13 364 0.6× 92 0.4× 348 1.7× 85 0.5× 192 1.4× 14 1.2k
Nicole Schlagwein Netherlands 12 753 1.2× 112 0.5× 170 0.9× 61 0.4× 75 0.5× 23 1.1k
Bethany Tesar United States 16 995 1.6× 67 0.3× 274 1.4× 101 0.6× 280 2.0× 32 1.5k
Sophie Hillion France 26 1.1k 1.9× 64 0.3× 268 1.3× 229 1.4× 173 1.2× 56 1.7k
Mohammad Afzal Khan Saudi Arabia 17 342 0.6× 222 1.1× 139 0.7× 97 0.6× 299 2.1× 40 852
Dorit Fabricius Germany 13 710 1.2× 64 0.3× 143 0.7× 39 0.2× 67 0.5× 33 1.0k
Giorgia Fanelli United Kingdom 12 883 1.4× 34 0.2× 315 1.6× 88 0.5× 110 0.8× 16 1.3k
Jiangnan Xu China 17 530 0.9× 84 0.4× 147 0.7× 32 0.2× 168 1.2× 34 911

Countries citing papers authored by Caroline Mary

Since Specialization
Citations

This map shows the geographic impact of Caroline Mary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Mary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Mary more than expected).

Fields of papers citing papers by Caroline Mary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Mary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Mary. The network helps show where Caroline Mary may publish in the future.

Co-authorship network of co-authors of Caroline Mary

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Mary. A scholar is included among the top collaborators of Caroline Mary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Mary. Caroline Mary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mérieau, Emmanuel, Caroline Mary, Kévin Biteau, et al.. (2024). CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury. The Journal of Immunology. 212(7). 1178–1187. 4 indexed citations
2.
Baccelli, Irène, Caroline Mary, Géraldine Teppaz, et al.. (2023). 493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoralin vivoefficacies in humanized preclinical models. SHILAP Revista de lepidopterología. A555–A555. 1 indexed citations
3.
Gauttier, Vanessa, Judith Fresquet, Isabelle Girault, et al.. (2023). ChemR23 activation reprograms macrophages toward a less inflammatory phenotype and dampens carcinoma progression. Frontiers in Immunology. 14. 1196731–1196731. 13 indexed citations
4.
Morello, Aurore, Justine Durand, Isabelle Girault, et al.. (2023). 1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy. SHILAP Revista de lepidopterología. A1526–A1526. 2 indexed citations
5.
Morello, Aurore, Justine Durand, Isabelle Girault, et al.. (2022). 1366 Anti-PD-1/IL-7v bispecific antibody promotes TCF1+ stem like T cells expansion and long-lasting in vivo efficacy. Regular and Young Investigator Award Abstracts. 1 indexed citations
6.
Gauttier, Vanessa, Kévin Biteau, Isabelle Girault, et al.. (2021). Abstract 1766: Triggering the resolution of inflammation with agonistic anti-ChemR23 antibody dampens inflammation-driven carcinogenesis. Cancer Research. 81(13_Supplement). 1766–1766. 1 indexed citations
7.
Nerrière‐Daguin, Véronique, Mélanie Néel, Jean‐Marie Heslan, et al.. (2021). SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation. Frontiers in Immunology. 12. 732530–732530. 29 indexed citations
8.
Pengam, Sabrina, Justine Durand, Claire Usal, et al.. (2019). SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells. American Journal of Transplantation. 19(12). 3263–3275. 34 indexed citations
9.
Le, Hoa, Julien Branchereau, Nicolas Poirier, et al.. (2019). Interleukin-7 receptor blockade by an anti-CD127 monoclonal antibody in nonhuman primate kidney transplantation. American Journal of Transplantation. 20(1). 101–111. 7 indexed citations
10.
Besançon, Alix, Fabrice Valette, Caroline Mary, et al.. (2018). A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice. Diabetologia. 61(8). 1811–1816. 8 indexed citations
11.
Laurent, Lætitia, Mélanie Néel, Caroline Mary, et al.. (2017). Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28. European Journal of Immunology. 47(8). 1368–1376. 15 indexed citations
12.
Poirier, Nicolas, Gilles Blancho, Caroline Mary, et al.. (2016). First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28. The Journal of Immunology. 197(12). 4593–4602. 47 indexed citations
13.
Vierboom, Michel, Yolanda S. Kap, Caroline Mary, et al.. (2015). Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. Clinical & Experimental Immunology. 183(3). 405–418. 20 indexed citations
14.
Poirier, Nicolas, Nahzli Dilek, Caroline Mary, et al.. (2014). FR104, an Antagonist Anti-CD28 Monovalent Fab’ Antibody, Prevents Alloimmunization and Allows Calcineurin Inhibitor Minimization in Nonhuman Primate Renal Allograft. American Journal of Transplantation. 15(1). 88–100. 69 indexed citations
15.
Poirier, Nicolas, Caroline Mary, Stéphanie Le Bas‐Bernardet, et al.. (2014). Advantages ofPapio anubisfor preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28. mAbs. 6(3). 697–706. 19 indexed citations
16.
Dilek, Nahzli, Nicolas Poirier, Philippe Hulin, et al.. (2013). Targeting CD28, CTLA-4 and PD-L1 Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells. PLoS ONE. 8(12). e83139–e83139. 54 indexed citations
17.
Mary, Caroline, Flora Coulon, Nicolas Poirier, et al.. (2013). Antagonist properties of monoclonal antibodies targeting human CD28. mAbs. 5(1). 47–55. 18 indexed citations
18.
Poirier, Nicolas, Caroline Mary, Nahzli Dilek, et al.. (2012). Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody. American Journal of Transplantation. 12(10). 2630–2640. 56 indexed citations
19.
Poirier, Nicolas, Nahzli Dilek, Caroline Mary, & Bernard Vanhove. (2012). Preclinical Efficacy and Immunological Safety of FR104, An Antagonist Anti-CD28 Monovalent Fabʼantibody, in Humanized Mice Models. Transplantation. 94(10S). 136–136. 1 indexed citations
20.
Mary, Caroline, Flora Coulon, Nicolas Poirier, et al.. (2012). Antagonist properties of monoclonal antibodies to human CD28: role of valency and heavy-chain constant domain. Journal of Translational Medicine. 10(S3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca A. Shilling Breakdown of academic impact, for papers by William van der Touw Breakdown of academic impact, for papers by Tracy Goodpaster Breakdown of academic impact, for papers by Nicole Schlagwein Breakdown of academic impact, for papers by Bethany Tesar Breakdown of academic impact, for papers by Sophie Hillion Breakdown of academic impact, for papers by Mohammad Afzal Khan Breakdown of academic impact, for papers by Dorit Fabricius Breakdown of academic impact, for papers by Giorgia Fanelli Breakdown of academic impact, for papers by Jiangnan Xu
Rankless by CCL
2026